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Direct-to-consumer genetic testing for disease ranges from well-validated diagnostic 
and predictive tests to ‘research’ results conferring increased risks. While being targeted 
at public curious about their health, they are also marketed for use in reproductive 
decision-making or management of disease. By virtue of being ‘direct-to-consumer’ 
much of this testing bypasses traditional healthcare systems. We argue that direct-to-
consumer genetic testing companies should make genetic counseling available, pre- 
as well as post-test. While we do not advocate that mandatory genetic counseling 
should gate-keep access to direct-to-consumer genetic testing, if the testing process 
has the potential to cause psychological distress, then companies have a responsibility 
to provide support and should not rely on traditional healthcare systems to pick up 
the pieces.
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online: 11 May 2017
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Setting the scene
There are many perceived benefits of direct-
to-consumer genetic testing (DTCGT). 
For countries that do not have established 
clinical genetics services already, there will be 
public who are only able to receive diagnostic 
or predictive genetic results via DTCGT [1]. 
If clinical utility and validity can be assured, 
then such results may indeed empower indi-
viduals to be more aware of the health prob-
lems that could affect them or their children 
and to take proactive steps in disease manage-
ment or prevention. However, there remains 
concern regarding the utility and validity of 
many direct-to-consumer (DTC) tests [2].
A DTCGT company may reveal 
pertinent results quicker than healthcare ser-
vices blighted by long waiting lists, and since 
results are delivered direct to the customer, 
they do not necessarily have to be entered into 
medical records, which may be preferable for 
those with specific privacy concerns.
However, amid the enthusiasm surround-
ing DTCGT, there has also been extensive 
debate and criticism covering scientific, 
clinical, ethical and legal issues [3,4]. The 
clinical validity and utility of certain tests, 
especially those for complex traits, have also 
been continuously questioned [2,5]. Many 
DTC companies lack involvement of clinically 
trained and regulated healthcare scientists or 
health professionals [6], and questions have 
been raised about the adequacy of consent 
processes [7] both in terms of informed choice 
and for secondary use of data for research by 
third parties [8,9]. Recent research also suggests 
that customers often need help to interpret 
their DTC personal disease risks correctly [10]. 
If customers are left confused or anxious by 
their results and are unable to receive adequate 
information and support from the DTCGT 
company themselves, then there is evidence to 
suggest they seek access to established health-
care services [11]. Such services, particularly if 
publicly funded, for example, National Health 
Service in the UK, do not necessarily have the 
resources to welcome DTC customers [12] and 
fear that valuable time will be spent explaining 
complex results that may have limited validity 
or for which no health management can be 
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offered [13]. Actual impact on healthcare services is not 
understood though, and it is still unknown whether 
the fear of impact is greater than the reality. In health-
care systems that are willing to see DTCGT customers, 
there is the potential for needless follow-up screening, 
based on limited efficacy, just because the customer is 
anxious [14]. There is also limited evidence to suggest 
that, on receipt of genetic risk results, people actually 
modify their lifestyle behaviors [15]. However, at the 
same time, there is always the potential that results are 
gleaned which, on an individual basis, are genuinely 
helpful in terms of health management or personal 
decision-making.
While some DTCGT companies require a health-
care professional (not necessarily a genetics expert) to 
order the test and/or to return results, other companies 
deliver genetic test results directly to the customer, 
usually via an online portal. Many customers report 
no long-term psychological distress from their 
results [16] and indeed many results, particularly 
from SNP-based, genome-wide studies are not clearly 
linked to disease. However, some customers have 
reported extreme anxiety and distress after receiving 
predictive cancer results and have found the informa-
tion and support offered by the DTCGT company to 
be severely lacking [17].
When DTCGT companies first came onto the 
market, there were concerns that the public would 
access services that ‘should’ remain under the control 
of clinicians [18,19]; it was implied that clinicians were 
putting unnecessary and paternalistic barriers in 
the way of access [20]. However, over time, there has 
been recognition that there are members of the public 
who, on receipt of disease risk results, would actually 
welcome the opportunity to talk these through with 
a suitably trained health professional [21]. Some com-
mercial companies now do indeed offer ‘genetic 
counseling’ as part of their testing package.
The involvement of a healthcare professional, as 
part of the DTCGT pathway, varies considerably 
between companies [22]. As such, there have been 
repeated calls for DTCGT companies to provide 
more consistent and a higher level of pre- and post-
test counseling from appropriately qualified health 
professionals [12,23–25]. Most recently, the American 
College of Medical Genetics has advised “A genetics 
expert such as a certified medical geneticist or genetic 
counsellor should be available to help the consumer 
determine, for example, whether a genetic test should 
be performed and how to interpret test results in light 
of personal and family history” [26]. Customers who do 
indeed seek out the services of a genetic counselor, 
post-DTCGT results, find this helpful in terms of 
informational content and support [27].
The focus of this perspective is on the provision 
of genetic counseling by DTCGT companies. We 
explored this by examining information provided by 
DTCGT companies on genetic counseling: what they 
write about it, if they offer it, and if so, how? As authors 
who are based in Europe, we have the European 
context of genetic counseling particularly in mind, and 
this Perspective is viewed via a European lens.
What is genetic counseling?
Although the classic definition of genetic counseling, 
as proposed by the American Society of Human 
Genetics in 1975 [28], has evolved over time, genetic 
counseling is still consistently described by profes-
sional bodies around the world as a client-centered 
communication process, designed to help people 
understand and adapt to the medical and psycho-
social consequences of either having, being at-risk 
from or passing on a genetic condition [29–32]. Despite 
recent discussion about whether the scope of genetic 
counseling practice accurately reflects the current 
ethos of the profession [33], it is generally accepted 
that professionals such as medically trained clinical 
geneticists and genetic counselors and genetic nurses 
perform the genetic counseling process, as defined 
above [34]. These professionals are typically trained to 
prepare clients for genetic testing, explain results and 
attend to their client’s needs with information gained 
from genetic tests.
Genetic counselors have expertise in the manage-
ment of genetic disease, what screening is appro-
priate, and more recently they are becoming skilled in 
variant interpretation. They can explain to a patient 
the difference between a variant of uncertain sig-
nificance and a pathogenic variant, and many are able 
to challenge whether a supposedly pathogenic variant 
does indeed fit the clinical phenotype [35]. Thus, 
their clinical knowledge forms part of the genetic 
counseling process.
Genetic counselors are also the healthcare 
professionals who primarily focus on the psychosocial 
and family communication issues that may arise 
from genetic (i.e., shared) information. In Europe, 
some countries offer an European Society of Human 
Genetics (ESHG)-approved training program or 
an MSc in genetic counseling [32]. A certification/
registration scheme is supervised by the ESHG, typically 
requiring 2 years of clinical practice as a genetic coun-
selor post-training plus the completion of a professional 
portfolio of work, assessed at Master’s level, to demon-
strate competency to practice as dictated by the relevant 
board [32]. Many of these bodies provide a regulatory 
role in monitoring patient safety and ensuring the 
quality of their registrants in practice.
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The delivery of genetic counseling
Historically, genetic counseling practice has relied 
upon models from medicine, education and mental 
health [36]. A person-oriented approach was proposed 
by Kessler in 1997 as a blend of the teaching and 
counseling models which are commonly touted 
as central tenets of practice [37]. While the first 
emphasizes education and the provision of infor-
mation, the counseling model enables an iterative 
and client-led discussion about the impact and use of 
this information.
In Europe, as in many places around the world, 
the delivery of genetic counseling is often performed 
face-to-face, with a small proportion via telephone 
or via video conferencing [38,39]. Communication 
is established via a two-way dialogue, where the 
counselor can hear the client’s story and interact with 
them, in real time, to explain information and help find 
solutions for management together. After the coun-
seling experience, it is common for genetic counselors 
to signpost clients to written material or to write a 
personalized summary letter [40]. Genetic counseling 
is thus not a simple one-way process where the client 
is invited to listen to or read material or watch a video. 
This latter service would be considered science com-
munication or education and is neither client centered 
(one of the pivotal tenants of genetic counseling) nor 
designed for dealing with the immediacy of potential 
psychological distress.
Genetic counseling within the DTCGT market
The ESHG recommends that commercial DTCGT 
companies provide face-to-face independent genetic 
counseling; such a service needs to be delivered by an 
appropriately trained professional [23]:
“Genetic counseling is the process through which 
information enables individuals to make their own 
free decisions about testing. A website cannot replace 
appropriate pre-test and post-test genetic counseling, 
which usually involves a face-to-face consultation with a 
knowledgeable professional” [23].
“DTC genetic testing and the advertisement of 
genetic tests of unproven benefit or without adequate 
independent genetic counseling are in opposition to the 
professional standards the ESHG sustains” [23].
In 2010, a review of 38 DTCGT company websites 
revealed that “many of the companies offering genetic 
testing services via the internet do not include genetic 
counseling at all in their services. Only a few urge 
customers to involve an expert before purchasing a gene 
test, and ‘counseling’ in most cases only is provided as 
written information via mail or via web-log” [41], in 
other words, it is not ‘genetic counseling’. In 2013, a 
discourse analysis of DTCGT websites explored the 
way ‘genetic counseling’ was represented; this revealed 
that of 20 (mostly US-based) companies offering 
DTC genetic testing, 14 did not provide genetic coun-
seling; of the six that did, none of this was offered face 
to face and ranged from ‘genetics education’ through 
to ‘lifestyle/health advice’ [25].
What are DTCGT companies offering?
In researching the current DTCGT climate for 
this article, we reviewed website content from com-
mercial DTCGT companies. A convenience sample 
of six companies was identified via an Internet search 
(using two search engines, Google and DuckDuckGo, 
with the terms ‘direct-to-consumer genetic test’ in 
August and September 2016; these were reviewed 
again in December 2016). Ignoring companies 
offering only ancestry or nutritional testing, we 
focused on companies offering some level of health-
related genetic testing that could be seen in Europe 
and members of the public in Europe could choose 
to seek out. The websites of DTCGT companies that 
we have explored are mostly from North America as 
well as from Europe. However, as the web heeds no 
geographical boundaries and customers from Europe 
have access to websites from North America (and vice 
versa), we have explored DTCGT websites irrespective 
of where the company is based.
Content of company websites was perused for 
information on ‘genetic counseling’. We par-
ticularly wanted to know if genetic counseling was 
offered to customers and if so, in what manner. The 
process of website content evaluation was based on 
expert evaluation of written material – reading the 
content and assessing whether this described the 
offer of ‘genetic counseling’ and if so, what this 
comprised. Furthermore, we explored whether 
this appeared to align with the profile of genetic 
counseling as described by relevant bodies such 
as the American College of Medical Genetics and 
Genomics, European Society of Human Genetics 
and the Genetic Counsellor Registration Board in 
the UK and Republic of Ireland. The intent of this 
was to gauge an impression of what services were on 
offer and whether genetic counseling as described by 
DTCGT companies stands up to the standards set by 
expert groups. The website review was exploratory in 
nature and intended to provide us with an impression 
as opposed to a rigorous and systematic evaluation. 
We suggest this approach should be considered as a 
pilot work from which more methodologically robust 
research in the future can be built. This article is 
written from our perspective; it does not pretend to 
be an empirical research study, but rather an opinion 
piece that includes limited empirical data.
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Based on the review of websites from six DTCGT 
companies, we found that the description of genetic 
counseling services varied; there was no consistency 
across companies. We are unable to infer the actual 
delivery of service as we were only able to view the 
description of the delivery as stated in the website 
content. While we scrutinized the websites as much 
as possible, we accept that we may have missed infor-
mation in the small print. However, our observations 
are based on what was obvious and clearly visible to 
readers and if we were members of the public, this is 
likely to be what they would view too. The following is 
a broad overview of our observations.
No mention of genetic counseling
One DTCGT company offered no information about 
genetic counseling nor any reference to interactions 
with health professionals. The website notes that infor-
mation about genetic tests is “adequately presented in 
an understandable and transparent manner, so it does not 
require interpretation by third parties” [42]. The com-
pany explains that “After the completed analysis you will 
receive personalized advice based on your genetic predis-
positions in form of a personal guidebook either as a hard 
copy or as a print ready PDF file” [43]. The website also 
states that customers should look for further appro-
priate medical advice to inform important personal 
and medical decisions, without, however, mentioning 
genetic counseling: “you should consult an appropriate 
professional for advice, which would be specific in terms of 
your particular situation” [44].
Reference to external genetic counseling services
One company that does not offer genetic counsel-
ing as part of their service delivery suggests that 
customers could seek genetic counseling from exter-
nal services. 23andMe includes links to certified 
genetic counseling bodies/societies where custom-
ers can seek specialized help from genetic counselors 
(e.g., National Society of Genetic Counsellors [45]): 
“We encourage you to talk to a genetic counselor, a health 
professional with special training in genetic conditions, 
prior to collecting your sample for testing to learn more 
so you can make an informed decision about whether 
testing is right for you” [46]. It is worth mentioning that 
European customers are unlikely to be able to easily 
access the services of American Genetic Counselors 
based in the USA.
On the 23andMe site available to British customers it 
offers ‘counseling resources’ to customers and provides 
a link to the Association of Genetic Nurses and Coun-
sellors, the Dutch Association of Genetic Counsellors, 
Swedish Society of Medical Genetics, Finnish Society 
of Medical Genetics and Danish Society of Medical 
Genetics. This implies that by contacting these orga-
nizations the customers can access genetic counseling 
support. However, specifically for the British customers 
it is not possible to see a genetic counselor simply by 
contacting the Association of Genetic Nurses and 
Counsellors nor by contacting any of the regional 
clinical genetics services directly. Due to the nature of 
the publicly funded National Health Service, referral 
for genetic counseling is usually possible via specific 
routes, for example, through a General Physician or a 
hospital specialist. So, while the impression is given by 
23andMe that it is easy to seek out a genetic counselor, 
the reality is somewhat different.
Health professional advice available
One company [47] offered advice from health pro-
fessionals stating that ‘a genetic consultation’ is offered 
as part of their service. On review of what is actually 
offered, in our opinion, the type of service provided 
is not actually the process of genetic counseling as 
endorsed by European professional bodies such as 
the Genetic Counsellor Registration Board [48] and 
the ESHG [49]. The genetic tests that are advertised 
“ include a medical consultation with a specialist,” not 
specifying the type of professional involved nor if they 
are trained in genetic counseling and board certified/
registered. Also, the wording of the website suggests 
this service is exclusively information based: “Before 
you order you will be able to talk with one of our advisors 
who will talk you through what these tests can and cannot 
deliver for you. All our tests include a consultation with 
one of our trained medical doctors. He/She will guide you 
through your report and advise you the steps to take to 
live a happier healthier life” [50]. The service is offered 
either remotely (by phone) or face to face in one of the 
company’s clinics.
Post-test genetic counseling offered only
Three companies offer genetic counseling upon 
request by the customer. In these cases, there is 
suggestion in the website that this possibility is 
specifically for post-test scenarios only, as it is 
directed to “explain/help understand your results,” “to 
plan for next steps,” or explicitly if results indicate a 
carrier test result: “During your scheduled appoint-
ment, our genetic counselors will review your report 
with you to help you understand your results, as well as 
discuss your potential next steps” ; “If your results indi-
cate that you are a carrier for a condition tested, Gene 
by Gene offers complimentary genetic counseling” [51]. 
While some companies do not specify how counsel-
ing was offered, others specifically mentioned the 
offer by phone: “a complimentary call with one of our 
genetic counselors to review your results upon request 
www.futuremedicine.com 253future science group
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(currently applies to the USA only)” [52]. None of the 
four companies we reviewed, which offered post-test 
genetic counseling, appeared to be explicitly available 
to non-USA-based customers.
Discussion
We conclude that most of the company websites we 
viewed mention the need for some form of healthcare 
counseling; a subset specifically mentions the process 
of genetic counseling; and none actually describe what 
they offer in a way that concurs with recommended 
standards of genetic counseling (i.e., both pre- and 
post-test counseling) and is available to European 
customers.
Drawing our conclusions based on experience as well 
as the limited empirical data we have presented here, we 
feel there is an urgent need for private companies selling 
genetic testing DTC to consider their delivery of care. 
They should also provide clarity regarding the services 
they offer or recommend, specifically when discussing 
the genetic counseling process. If DTCGT companies 
offer health-related genetic testing that requires genetic 
counseling in the traditional healthcare setting, then 
why should it be accepted that companies sell them 
without both pre- and post-test genetic counseling? If 
genetic testing is offered, adequate counseling should 
be available with respect to the nature and potential 
impact of the test.
If DTCGT companies do indeed intend to offer 
genetic counseling, then this should align with 
professional genetic counseling body recommendations 
(and should be clear on their websites). Genetic 
counseling, as described by the ESHG [49], is a process 
that is delivered by appropriately trained and regulated 
professionals. It would be very helpful if websites could 
clearly explain what genetic counseling is and what it 
can offer.
One striking aspect of the services offered by the 
DTCGT companies we explored is the lack of pretest 
genetic counseling. This is in contrast to DTCGT 
recommendations by the ESHG [23], American College 
of Medical Genetics and Genomics [26] and the UK 
Human Genetics Commission [53], which state that 
pretest genetic counseling and psychosocial support 
should be offered as part of the testing process. Indeed, 
a key aspect of providing a quality counseling service 
is to help clients discuss all options in advance of 
making their final decisions to proceed or not. While 
it is clearly unnecessary for ‘recreational’ genetic 
testing, this becomes more pertinent for diagnostic, 
predictive or carrier testing for serious, potentially 
life-threatening conditions.
We acknowledge that information about genetic 
testing can be communicated in many ways to 
customers. Written and video materials full of infor-
mational content are very helpful. However, such 
information should not, in any way, be labeled 
or implied to be ‘genetic counseling’ or give the 
impression that this is a substitute for psychosocial 
support. Authentic genetic counseling is a two-way 
dialogue, where the counselor can hear the client’s 
story and interact with them, in real time, to support 
them and help find solutions together.
What is key here is that customers may not be 
able to anticipate their psychological needs until they 
obtain a result that causes them anxiety. We also 
know that people who have genetic testing may not 
be able to identify psychosocial issues as effectively as 
they are able to recognize the need for information or 
explanation [54].
Although, of course, the provision of informa-
tion stands as a key element in the genetic counseling 
process, studies suggest the crucial need to adapt the 
information to previous knowledge and existing beliefs 
of patients, as a way to enhance their understanding 
while integrating it with intra- and inter-personal 
characteristics [55,56]. While DTCGT companies 
commonly offer information about the tests being 
sold, there are limited grounds on how to make sure 
the information is fully understood by the customer 
and adequately accommodated in their wider life 
circumstances (namely, in terms of psychosocial well-
being and the communication of risk information to 
relevant at-risk family members).
While we do not advocate that mandatory genetic 
counseling should gate-keep access to all DTCGT, 
we do suggest that it is mandatory to clearly explain 
in the companies’ websites what the role of genetic 
counseling is and make it easily available, pre- as well 
as post-test, by appropriately trained and regulated 
genetic health professionals, so that at any point in 
the process of testing, customers have someone to 
turn to if needed. We also strongly suggest that when 
the term ‘genetic counselor’ or ‘genetic counseling’ 
is used, there is clear evidence of the professional 
qualifications, training and certification that pro-
fessionals have, together with a clear description of 
what genetic counseling is and can offer. Given that 
the Web has no geographical boundaries, DTCGT 
companies should also spell out exactly which web-
based customers can access services and whether these 
are only available in certain countries or not. It is also 
potentially negligent to suggest that customers can 
‘contact their local genetic counselor’ when there are 
no mechanisms to actually do this in reality. It is also 
negligent for companies to offer testing that raises 
anxiety among their customers and then expect other 
healthcare services to pick up the pieces.
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Future perspective
When speculating on a future perspective about how 
the DTCGT field will evolve over the next 5–10 years, 
we anticipate that, given reducing costs of sequencing 
and increased application of sequencing in a 
clinical setting, the commercial market has the poten-
tial to grow exponentially. If recommendations from 
genetic health professionals and their professional 
bodies are heeded, then there is an urgent need to train 
a whole workforce of industry genetic counselors to 
meet the demand for jobs with DTCGT companies. 
However, despite recommendations to incorporate 
genetic counseling we suspect that companies may not 
do this in reality until they receive customer pressure 
to do so. As DTCGT becomes more easily available 
and more customers access it, we feel that it will not 
be long before cases emerge of customers experiencing 
tangible psychological damage from the results of 
tests linked to serious, life-threatening conditions. 
Take, for example, a healthy customer who has a 
DTC clinical exome done ‘for curiosity’. The results 
reveal a variant of uncertain significance in a breast–
ovarian cancer gene; the customer sees ‘breast–ovar-
ian gene’ and mistakenly believes that she needs to 
have breast screening together with a discussion of 
risk-reducing mastectomy. As the majority of nonge-
netics health professionals have not yet had training 
in genomics, it is distinctly possible that the radiolo-
gist and breast surgeon she approaches may also not 
appreciate that a variant of uncertain significance 
does not need clinical action. It is easy to see how a 
misinterpreted result may lead to unnecessary screen-
ing and possible surgery. The consequences of this 
from both, a psychological and a physical perspec-
tive, are obvious. Involving a genetic counselor in the 
DTC process could have alleviated all of this.
We suggest that much more empirical research 
is needed to explore, over time, what the long-
term psychosocial impact is, particularly for DTC 
customers who receive a ‘high-risk’ result relating to 
serious potentially life-threatening conditions. Given 
that such customers have elected to buy their tests out-
side of a healthcare service, there is no ‘system’ that 
they belong to – so finding them (to ask if they need 
support or to gather their views on their experience) 
is difficult without involving the DTCGT companies 
Table 1. Direct-to-consumer genetic testing companies and genetic counseling services.
Company Country as stated by 
the address provided 
on the website
Access date Healthcare 
professional 
involved?
Mention of GC Ref. 
 
1. No mention of GC
Gene 
Planet
Slovenia (with 
laboratories in 
Sweden and Ohio)
4 December 
2016
No No GC mentioned or offered [57]
2. Includes reference to external GC services
23andMe USA (we accessed 
the site for British 
customers)
4 December 
2016
No No GC offered, but GC mentioned, and customers 
are advised to contact local ‘counseling resources’, 
for example. the Association of Genetic Nurses 
and Counsellors in the UK ‘if you are concerned’. 
This is the incorrect way to access GC in the UK
[58]
3. Health professional advice is available
Genetic 
Health
UK 4 December 
2016
Yes Offers pre- and post-consultation support with 
a ‘genetic-trained advisor’ (but not labeled as 
someone specialist in GC)
[47]
4. Post-test GC is offered
Veritas USA, China, 
Luxembourg
4 December 
2016
Yes Offers GC post-test with a board certified genetic 
counselor (but only for US customers) 
[52]
Gene by 
Gene
USA 4 December 
2016
Yes Offers GC post-test with a board certified 
genetic counselor (but appears to be only for US 
customers)
[51]
Sure 
Genomics
USA 4 December 
2016
Yes Offers 1-h post-test GC with a board certified 
genetic counselor (but appears to be only for US 
customers)
[59]
GC: Genetic counseling.
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themselves. Another consequence of not being part 
of a healthcare system is that they have no continuity 
of care for themselves or other possible at-risk family 
members. Any long-term psychological or clinical 
follow-up would be at the discretion and responsibility 
of the DTCGT company, and yet such companies 
have no vested interest in discovering whether their 
tests are causing psychological or physical harm. More 
research is needed, by independent researchers, on the 
beneficial and harmful consequences of high-risk test 
results. Such researchers will need to think creatively 
about how they will access DTCGT customers and any 
research they conduct should be longitudinal, so that 
changing attitudes can be captured. In addition to this, 
the ‘impact of the test’ has potentially far reaching con-
sequences for the family that extend beyond the indi-
vidual tested. Thus, research should also cover: if and 
how customers share their results with their biological 
relatives (and how this is received), what the impact has 
been on their own clinical management (and the costs 
of this) and whether they have been on the receiving 
end of any discrimination as a result of the test.
Finally, although we are offering mainly a European 
perspective, it is likely that our discussion points are 
relevant to a non-European setting and we encourage 
debate and exploration of the nuances surrounding 
this (Table 1).
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Executive summary
Setting the scene
•	 Direct-to-consumer genetic testing (DTCGT) for disease ranges from well-validated diagnostic and predictive 
tests to ‘research’ results conferring increased risks.
•	 While being targeted at public curious about their health, they are also marketed for use in reproductive 
decision-making or management of disease.
•	 By virtue of being ‘direct-to-consumer’ much of this testing bypasses traditional healthcare systems.
Genetic counseling within the DTCGT market
•	 ”A genetics expert such as a certified medical geneticist or a genetic counselor should be available to help 
the consumer determine, for example, whether a genetic test should be performed and how to interpret test 
results in light of personal and family history” (American College of Medical Genetics).
•	 ”Direct-to-consumer genetic testing and the advertisement of genetic tests of unproven benefit or without 
adequate independent genetic counseling are in opposition to the professional standards the European 
Society of Human Genetics sustains” (European Society Human Genetics).
•	 Genetic counselors have expertise in the management of genetic disease, what health screening is 
appropriate, and more recently they are becoming skilled in variant interpretation.
•	 Genetic counselors are also the healthcare professionals who primarily focus on the psychosocial and family 
communication issues that may arise from genetic (i.e., shared) information.
•	 DTCGT companies should make genetic counseling available, pre- as well as post-test.
Discussion
•	 While we do not advocate that mandatory genetic counseling should gate-keep access to DTCGT, if the testing 
process has the potential to cause psychological distress, then companies have a responsibility to provide 
support and should not rely on traditional healthcare systems to pick up the pieces.
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